Apollo Economist Highlights AI Profit Delays in Regulated Sectors
AI readiness in regulated sectors lags behind tech, challenging overly optimistic Wall Street forecasts through 2027.
What Changed
Apollo chief economist Torsten Slok has noted that AI profit gains in regulated industries such as healthcare, banking, and pharmaceuticals may face significant delays. While AI technologies promised swift advancements, Slok argues that real productivity boosts could take five years, considerably longer than initial expectations of five months. This delay places additional pressure on AI stock valuations, which relied on more immediate benefits.
Strategic Implications
Regulated industries now face the challenge of adjusting to a longer timeline for AI-driven efficiencies. Companies reliant on AI for cost reductions and process overhauls will need to recalibrate their financial strategies, potentially losing leverage to faster-moving tech-focused industries. Moreover, these delays could benefit AI consultancies that provide strategies for navigating regulatory landscapes.
What Happens Next
Investors and companies in sectors like healthcare and banking should prepare for extended timelines by diversifying investments or seeking strategic partnerships. Regulatory agencies may see increased influence as industries depend on compliance to unlock AI advantages. Enterprises should anticipate policy advisories by the third quarter of 2027 as they navigate these new realities.
Second-Order Effects
The delays might affect adjacent markets related to AI software and compliance tools, with a potential increase in demand for AI policy advisors. Additionally, investment in AI-driven supply chain optimization might slow, impacting global trade dynamics. These developments could lead to higher volatility in stock markets as expectations adjust.
Free Daily Briefing
Top AI intelligence stories delivered each morning.